Baker Z, Zhang Y, Zhang H, Franklin H, Serpa P, Southard T
Nat Biotechnol. 2025; .
PMID: 39966654
DOI: 10.1038/s41587-025-02570-7.
Li G, Ma J, Yu H, Tsahouridis O, Lou Y, He X
bioRxiv. 2025; .
PMID: 39763958
PMC: 11702585.
DOI: 10.1101/2024.12.16.628615.
Ma C, Li Y, Li M, Lv C, Tian Y
Cancer Immunol Immunother. 2025; 74(2):40.
PMID: 39751898
PMC: 11699031.
DOI: 10.1007/s00262-024-03856-6.
Akula S, Alvarado-Vazquez A, Haide Mendez Enriquez E, Bal G, Franke K, Wernersson S
Int J Mol Sci. 2024; 25(23).
PMID: 39684762
PMC: 11642334.
DOI: 10.3390/ijms252313050.
Wang L, Dong Z, Zhang Y, Peng L
J Clin Transl Hepatol. 2024; 12(12):1043-1056.
PMID: 39649031
PMC: 11622203.
DOI: 10.14218/JCTH.2024.00317.
Exploring Glycan-Lectin Interactions in Natural-Like Environments: A View Using NMR Experiments Inside Cell and on Cell Surface.
Bertuzzi S, Lete M, Franconetti A, Diercks T, Delgado S, Oyenarte I
Chemistry. 2024; 31(10):e202403102.
PMID: 39588609
PMC: 11833217.
DOI: 10.1002/chem.202403102.
Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects.
Wolters-Eisfeld G, Oliveira-Ferrer L
Semin Immunopathol. 2024; 46(6):16.
PMID: 39432076
PMC: 11493797.
DOI: 10.1007/s00281-024-01025-6.
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?.
Du R, Zhang J, Lukas R, Tripathi S, Ahrendsen J, Curran M
Neuro Oncol. 2024; 27(1):33-49.
PMID: 39427326
PMC: 11726257.
DOI: 10.1093/neuonc/noae193.
Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosis.
Song D, Li Z, Sun F, Wu K, Zhang K, Liu W
Stem Cell Res Ther. 2024; 15(1):344.
PMID: 39380037
PMC: 11462801.
DOI: 10.1186/s13287-024-03945-4.
Siglec-G Suppresses CD8 T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.
Yin S, Li C, Shen X, Yu G, Cui L, Wu Y
Adv Sci (Weinh). 2024; 11(45):e2403438.
PMID: 39373395
PMC: 11615767.
DOI: 10.1002/advs.202403438.
Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection.
Rzymski P, Brzdek M, Dobrowolska K, Poniedzialek B, Murawska-Ochab A, Zarebska-Michaluk D
Viruses. 2024; 16(9).
PMID: 39339862
PMC: 11435954.
DOI: 10.3390/v16091386.
CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers.
Zhao C, Huang Y, Zhang H, Liu H
Discov Oncol. 2024; 15(1):399.
PMID: 39222166
PMC: 11369128.
DOI: 10.1007/s12672-024-01284-7.
Dissecting the lung transcriptome of pulmonary fibrosis-associated pulmonary hypertension.
Brownstein A, Mura M, Ruffenach G, Channick R, Saggar R, Kim A
Am J Physiol Lung Cell Mol Physiol. 2024; 327(4):L520-L534.
PMID: 39137526
PMC: 11482468.
DOI: 10.1152/ajplung.00166.2024.
Structure and Functions of HMGB3 Protein.
Chikhirzhina E, Tsimokha A, Tomilin A, Polyanichko A
Int J Mol Sci. 2024; 25(14).
PMID: 39062899
PMC: 11276821.
DOI: 10.3390/ijms25147656.
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells.
van Bruggen J, Peters F, Mes M, Rietveld J, Cerretani E, Cretenet G
Blood Adv. 2024; 8(17):4633-4646.
PMID: 39042920
PMC: 11401197.
DOI: 10.1182/bloodadvances.2023011934.
HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage.
Yuan J, Guo L, Ma J, Zhang H, Xiao M, Li N
Cell Biol Toxicol. 2024; 40(1):55.
PMID: 39008169
PMC: 11249443.
DOI: 10.1007/s10565-024-09893-2.
A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy.
Van Delen M, Derdelinckx J, Wouters K, Nelissen I, Cools N
J Extracell Vesicles. 2024; 13(7):e12458.
PMID: 38958077
PMC: 11220457.
DOI: 10.1002/jev2.12458.
Assessing the causal relationship between circulating immune cells and abdominal aortic aneurysm by bi-directional Mendelian randomization analysis.
Ruan W, Zhou X, Wang T, Liu H, Zhang G, Sun J
Sci Rep. 2024; 14(1):13733.
PMID: 38877212
PMC: 11178833.
DOI: 10.1038/s41598-024-64789-9.
Clinical landscape of macrophage-reprogramming cancer immunotherapies.
Rannikko J, Hollmen M
Br J Cancer. 2024; 131(4):627-640.
PMID: 38831013
PMC: 11333586.
DOI: 10.1038/s41416-024-02715-6.
Neutrophils disrupt B-1a cell homeostasis by targeting Siglec-G to exacerbate sepsis.
Tan C, Reilly B, Ma G, Murao A, Jha A, Aziz M
Cell Mol Immunol. 2024; 21(7):707-722.
PMID: 38789529
PMC: 11214631.
DOI: 10.1038/s41423-024-01165-7.